SEC Form 4 · accession 0000899243-17-002847
CRYO CELL INTERNATIONAL INC · CCEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jill M Taymans
Officer — VP, Finance, CFO
Period of report
Feb 1, 2017
Accepted (ET)
Feb 6, 2017 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000862692
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2017 | M | 9,281 | $1.50 | A | 45,396 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $1.50 | Feb 1, 2017 | M | 9,281 | D | — | Feb 1, 2017 | Common Stock | 9,281 | 0 | D |
| Stock OptionF1 | $3.10 | Jun 2, 2016 | A | 7,500 | A | — | Jun 2, 2026 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F11/3 vest one year from date of grant, 1/3 vest two years from date of grant, 1/3 vest three years from date of grant